Article citationsMore>>

J. S. Lee, K. Park, S. Kim, et al., “A Randomized Phase III Study of Gefitinib (IRESSATM) versus Standard Chemotherapy (Gemcitabine Plus Cisplatin) as First-Line Treatment for Never Skmokers with Advanced or Metastatic Adenocarcinoma of the Lung,” Journal of Thoracic Oncology, Vol. 4, No. 9, 2009, p. S283.

has been cited by the following article: